When AbbVie’s record-breaking immunotherapy drug Humira went off patent early last year after generating more than $200 billion …
Copyright ©️ All rights reserved. | US Global Health
Tag:
Humira
-
-
Patients being treated for autoimmune diseases will see some of their out-of-pocket costs reduced when biosimilar versions of …
-
(Bloomberg) – America’s largest drug benefit manager is moving to take a slice of sales of one of …
-
The logo of German pharmaceutical company Boehringer Ingelheim is seen on the company’s building in Shanghai, China, on …
-
By Patrick Wingrove Reuters – Pharmaceutical partners Organon and Samsung Bioepis said Saturday they have launched a much …
-
Reuters – Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie’s blockbuster arthritis …
-
April 27 (Reuters) – AbbVie (ABBV.N) on Thursday underperformed its quarterly sales estimates for its new therapeutics as …